Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 02/24/20 → 12/15/22 |
Funding
- Alexion Pharmaceuticals Incorporated: $16,550.00
Syneos Health: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naive Adult Patients with Generalized Myasthenia Gravis
- Pourmand, Rahman (PI)
- Treidler, Simona (CoPI)
Project: Research